ROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

Haidi Karam-Allah Ramadan; Gellan Ahmed; Waleed Hassan

doi:10.21608/bfsa.2022.271687

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Haidi, K. R., Gellan, A., Waleed, H. (2022). ROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. Bulletin of Pharmaceutical Sciences Assiut. https://doi.org/10.21608/bfsa.2022.271687

Remal Asaad · 2022

cites

386

IN-VITRO AND IN-VIVO HYPOGLYCEMIC EFFICACY OF ROSA DAMASCENA PETALS EXTRACTS

Abed Alsalti; Nouma Hasan; Dima Aldia · 2022

cites

392

DEVELOPMENT OF FOUR UV-SPECTROMETRIC TECHNIQUES FOR CONCURRENT ESTIMATION OF ASPIRIN AND SILDENAFIL …

Amir Alhaj Sakur; Zahraa Kayali · 2022

cites

386

ASSOCIATION BETWEEN ANTIBIOTIC RESISTANCE, BIOFILM FORMATION AND LASB GENE IN PSEUDOMONAS AERUGINOSA…